granirex
rex medical ltd - granisetron hydrochloride 1.12mg equivalent to 1.0 mg granisetron base - film coated tablet - 1 mg - active: granisetron hydrochloride 1.12mg equivalent to 1.0 mg granisetron base excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry white 04f58804 purified water sodium starch glycolate - granisetron is indicated for the prevention of acute and delayed nausea and vomiting associated with cytostatic therapy
granirex
rex medical ltd - granisetron hydrochloride 0.112 mg/ml - solution for injection - 0.1 mg/ml - active: granisetron hydrochloride 0.112 mg/ml excipient: citric acid monohydrate hydrochloric acid sodium chloride sodium hydroxide water for injection - granisetron is indicated for the prevention of acute and delayed nausea and vomiting associated with cytostatic therapy, and for the prevention and treatment of post-operative nausea and vomiting.
granirex
rex medical ltd - granisetron hydrochloride 1.12 mg/ml - solution for injection - 1 mg/ml - active: granisetron hydrochloride 1.12 mg/ml excipient: citric acid monohydrate hydrochloric acid methyl hydroxybenzoate propyl hydroxybenzoate sodium chloride sodium hydroxide water for injection - granisetron is indicated for the prevention of acute and delayed nausea and vomiting associated with cytostatic therapy, and for the prevention and treatment of post-operative nausea and vomiting.
ranilex 28.227 mg/125 mg/100 mg/50 mg film-coated tablet
altomed pharmaceuticals, inc.; distributor: altomed pharmaceuticals, inc. - ranitidine (as hydrochloride) / magnesium aluminosilicate / magnesium aluminum hydrate / magnesium oxide - film-coated tablet - 28.227 mg/125 mg/100 mg/50 mg
ranirex 25mg/ ml (50mg/ 2ml) solution for injection (im/iv)
for: advacare international limited; importer: aarex pharma distributor; distributor: aarex pharma distributor - ranitidine hydrochloride - solution for injection (im/iv) - 25mg/ ml (50mg/ 2ml)
ranirex 25 mg/ml (50 mg/2 ml) solution for injection (im/iv)
n/a; importer: aarex pharma distributor; distributor: n/a - ranitidine hydrochloride - solution for injection (im/iv) - 25 mg/ml (50 mg/2 ml)
ranimax 150 mg tab tablet
jazeera pharmaceutical industries (jpi) - ranitidine - tablet - 150 mg
ranimax 300 mg tab tablet
jazeera pharmaceutical industries (jpi) - ranitidine - tablet - 300 mg
ranimax ac tablet
jazeera pharmaceutical industries (jpi) - ranitidine - tablet - 75 mg
ranimax ac tablet
jazeera pharmaceutical industries (jpi) - ranitidine - tablet - 75 mg